Description

Mycronic: Initiation of Coverage- ASEAN Expansion Ignites Global Growth Engine!

Mycronic AB’s first quarter results for the year have presented a mixed bag of developments, reflecting both impressive accomplishments and existing challenges. The company’s performance was highlighted by a strong year-over-year increase in several key metrics, yet there were softness and concerns in certain sectors. On the positive side, Mycronic recorded an impressive 25% increase in order intake, pushing the figure beyond SEK 2 billion, alongside a record sales increase of 27% year-over-year up to SEK 2.14 billion. Notably, the EBIT reached its highest level for a single quarter at SEK 775 million, equating to a significant margin of 36%. The company’s backlog remains healthy at SEK 4.6 billion, indicating sustained demand and potential for steady performance moving forward.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!